C

CG Oncology Inc
NASDAQ:CGON

Watchlist Manager
CG Oncology Inc
NASDAQ:CGON
Watchlist
Price: 39.84 USD -0.75% Market Closed
Market Cap: 3.2B USD

Intrinsic Value

The intrinsic value of one CGON stock under the Base Case scenario is 34.79 USD. Compared to the current market price of 39.84 USD, CG Oncology Inc is Overvalued by 13%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CGON Intrinsic Value
34.79 USD
Overvaluation 13%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
CG Oncology Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about CGON?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is CGON valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for CG Oncology Inc.

Explain Valuation
Compare CGON to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CGON?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
CG Oncology Inc

Current Assets 695.8m
Cash & Short-Term Investments 680.3m
Receivables 515k
Other Current Assets 15m
Non-Current Assets 34.1m
PP&E 19.5m
Intangibles 14.5m
Other Non-Current Assets 114k
Current Liabilities 30.5m
Accounts Payable 9.2m
Accrued Liabilities 20.8m
Other Current Liabilities 544k
Non-Current Liabilities 11.7m
Long-Term Debt 3m
Other Non-Current Liabilities 8.7m
Efficiency

Free Cash Flow Analysis
CG Oncology Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
CG Oncology Inc

Revenue
2.2m USD
Cost of Revenue
-2.1m USD
Gross Profit
89k USD
Operating Expenses
-180.2m USD
Operating Income
-180.1m USD
Other Expenses
28.6m USD
Net Income
-151.5m USD
Fundamental Scores

CGON Profitability Score
Profitability Due Diligence

CG Oncology Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

Low Gross Margin
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
18/100
Profitability
Score

CG Oncology Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

CGON Solvency Score
Solvency Due Diligence

CG Oncology Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

CG Oncology Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CGON Price Targets Summary
CG Oncology Inc

Wall Street analysts forecast CGON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CGON is 72.97 USD with a low forecast of 55.55 USD and a high forecast of 105 USD.

Lowest
Price Target
55.55 USD
39% Upside
Average
Price Target
72.97 USD
83% Upside
Highest
Price Target
105 USD
164% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

CG Oncology Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for CGON is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

CGON Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CGON stock?

The intrinsic value of one CGON stock under the Base Case scenario is 34.79 USD.

Is CGON stock undervalued or overvalued?

Compared to the current market price of 39.84 USD, CG Oncology Inc is Overvalued by 13%.

Back to Top